SOD2 and metabolic dysfunction-associated steatotic liver disease: Indeed, the specific activity of Cu/Zn-SOD was elevated by 60% in liver biopsies obtained from MASLD patients than in control livers; contrarily, no significant differences in hepatic Mn-SOD nor in erythrocytic Cu/Zn-SOD activity were observed (Perlemuter et al. 2005).